An automated microfluidic biosensor with bispecific rabbit monoclonal antibody and nanozyme-bioenzyme composite for dual antibiotic detection
Fuyuan Zhang , Yang Liu , Juntao Wang , Haichao Zhang , Wenlong Yu , Yaxin Sang , Yun Liu , Guangze Yang , Fang Gao , Shuo Wang , Shilun Feng , Xianghong Wang
BMEMat ›› 2026, Vol. 4 ›› Issue (1) : e70039
The detection of antibiotic residues in environmental water sources represents a critical ecological challenge with significant implications for public health. Conventional immunoassays for antibiotics often suffer from limitations in sensitivity and efficiency, primarily due to the lack of high-performance detection antibodies and the complexity of current operational procedures. In this study, we introduce a novel approach by bioengineering a florfenicol (FF) and thiamphenicol (THF) bispecific rabbit monoclonal antibody (rmAb) for the first time, which has been integrated into an automated microfluidic biosensor. This innovative biosensor employs an AuPtCu@HRP-hapten composite nanozyme-bioenzyme, demonstrating exceptional peroxidase-mimic catalytic activity. The automated immunosensor operates within a single microfluidic chip, enhancing both the simplicity and efficiency of the detection process. The rmAbs are non-destructively immobilized on protein A-functionalized agarose microspheres, serving as effective immunoreactive carriers. By introducing a smartphone sensing strategy, our biosensor achieved the detection of FF and THF residues in river water at remarkably low concentrations of 0.014 and 0.015 ng/mL within just 30 min, respectively. The method exhibits average recoveries between 96.58% and 104.50%, with standard deviations consistently below 5.34%. This sensing strategy not only significantly reduces detection time compared to traditional direct competitive immunoassays but also enhances sensitivity and accuracy. This user-friendly biosensor represents a promising advancement in antibiotic detection technology, making it well-suited for on-site applications and paving the way for future development of robust antibiotic sensing platforms.
florfenicol / microfluidic chip / nanozyme-bioenzyme / rabbit monoclonal antibody / thiamphenicol
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
|
| [38] |
|
| [39] |
|
| [40] |
|
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
|
2025 The Author(s). BMEMat published by John Wiley & Sons Australia, Ltd on behalf of Shandong University.
/
| 〈 |
|
〉 |